Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | CRSP | XENE | ||
| Company | Eidos Therapeutics Inc | Crispr Therapeutics Ag | Xenon Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 127.57 | 47.10 | 56.00 | ||
| High | 128.49 | 49.95 | 57.44 | ||
| Low | 116.83 | 47.10 | 55.86 | ||
| Latest | 122.21 | 49.51 | 56.85 | ||
| Change | -6.23 | +0.70 | +0.16 | ||
| % Change | -4.85% | +1.43% | +0.28% | ||
| Volume | 335,500 | 1,727,800 | 897,500 | ||
| 20-Day Average Volume | 113,985 | 2,362,460 | 2,381,860 | ||
| Previous Close | 128.44 | 48.81 | 56.69 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 48.95 | 55.66 | ||
| 20-Day Raw Stochastic | 36.63% | 36.08% | 69.00% | ||
| 20-Day Relative Strength | 56.42 | 47.86 | 61.57 | ||
| Weighted Alpha | +136.62 | +27.50 | +79.56 | ||
| Today's Opinion | 88% Buy | 88% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 8% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | +4.12% since 03/26/26 | +2.38% since 03/26/26 | ||
| Low | 116.83 on 01/25/21 | 44.12 on 03/30/26 | 53.62 on 03/30/26 | ||
| High | 131.08 on 01/20/21 | 49.95 on 04/02/26 | 59.44 on 04/01/26 | ||
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | -18.53% since 03/02/26 | +33.61% since 03/02/26 | ||
| Low | 116.24 on 01/05/21 | 44.12 on 03/30/26 | 41.05 on 03/06/26 | ||
| High | 132.54 on 01/04/21 | 60.60 on 03/04/26 | 63.95 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | -7.92% since 01/02/26 | +27.78% since 01/02/26 | ||
| Low | 69.38 on 10/30/20 | 44.12 on 03/30/26 | 39.29 on 01/20/26 | ||
| High | 132.54 on 01/04/21 | 61.76 on 02/26/26 | 63.95 on 03/10/26 | ||
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | -32.01% since 10/02/25 | +45.03% since 10/02/25 | ||
| Low | 38.44 on 07/31/20 | 44.12 on 03/30/26 | 37.23 on 11/07/25 | ||
| High | 132.54 on 01/04/21 | 78.48 on 10/08/25 | 63.95 on 03/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 4,752,217 | 4,729,352 | ||
| Shares Outstanding, K | 38,873 | 95,985 | 83,190 | ||
| Annual Sales | 26,690,000 | 3,510,000 | 7,500,000 | ||
| Annual Net Income | -37,840,000 | -581,600,000 | -345,910,000 | ||
| Last Quarter Sales | 130,000 | 860,000 | 0 | ||
| Last Quarter Net Income | -30,180,000 | -130,610,000 | -105,260,000 | ||
| 60-Month Beta | -0.16 | 1.80 | 0.74 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.37 on 02/12/26 | -1.31 on 02/26/26 | ||
| Latest Earnings Date | 02/24/21 | 05/05/26 | 05/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||